Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
Clinical trial NCT00901927 · TERMINATED
Trial details
- NCT number
- NCT00901927
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.